FUT2 (fucosyltransferase 2) determines secretor status: about 80 % of individuals are 'secretors' and express ABO blood group antigens in bodily fluids. These antigens act as receptors for gut bacteria and viruses. Non-secretors (carrying loss-of-function FUT2 variants) show altered gut microbiome composition – fewer Bifidobacteria, more potentially pathogenic taxa – and increased susceptibility to norovirus infection and Crohn’s disease. Evidence comes mainly from observational and GWAS studies; RCTs are lacking. Effect sizes are modest, and individual prediction is limited. A DNA test can identify FUT2 variants, but the clinical utility for diet or health management is low. Gut health is more strongly shaped by diet, medications, and lifestyle. Safety note: FUT2 variants are not a diagnosis; persistent gastrointestinal symptoms warrant medical evaluation.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5ba1e7c9f8da649ddf5b88d4